Literature DB >> 23638781

A psychological view of sexual pain among women: applying the fear-avoidance model.

Johanna Thomtén1, Steven J Linton.   

Abstract

AIM: The purpose of this paper is to examine how well research findings on dyspareunia (intercourse pain) fit the fear-avoidance (FA) model on pain.
RESULTS: The evidence suggests that the experience of pain in dyspareunia functions similarly to the pain reported in other pain conditions. There are also accumulating data showing that the central mechanisms of the FA model, such as catastrophizing, fear, hypervigilance and disability, are central to the experience of sexual pain. However, there are also some potential differences between sexual pain and other pain conditions that demand further attention in terms of the role of the partner, specific emotional consequences of avoidance and the effect of hypervigilance on sexual arousal.
CONCLUSION: The results demonstrate the relevance of the FA model in sexual pain. They also imply that treatment methods for fear and avoidance in other pain conditions offer new avenues for treating sexual pain problems in the clinic. Future studies should focus on expanding how the mechanisms in the FA model contribute to sexual pain, as well as how treatments based on the model may be applied clinically.

Entities:  

Mesh:

Year:  2013        PMID: 23638781     DOI: 10.2217/whe.13.19

Source DB:  PubMed          Journal:  Womens Health (Lond)        ISSN: 1745-5057


  2 in total

1.  Women's sexual health in later life: Gaps and opportunities in research and practice.

Authors:  Alexandra Ch Nowakowski; J E Sumerau
Journal:  Womens Health (Lond)       Date:  2019 Jan-Dec

2.  Improvements following multimodal pelvic floor physical therapy in gynecological cancer survivors suffering from pain during sexual intercourse: Results from a one-year follow-up mixed-method study.

Authors:  Marie-Pierre Cyr; Rosalie Dostie; Chantal Camden; Chantale Dumoulin; Paul Bessette; Annick Pina; Walter Henry Gotlieb; Korine Lapointe-Milot; Marie-Hélène Mayrand; Mélanie Morin
Journal:  PLoS One       Date:  2022-01-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.